ACS Omega (Jun 2024)

Retraction of “Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2”

  • Ming-feng Yang,
  • Sheng-yao Sun,
  • Hai-guang Lv,
  • Wei-qi Wang,
  • Han-xia Li,
  • Jing-yi Sun,
  • Zong-yong Zhang

DOI
https://doi.org/10.1021/acsomega.4c03199
Journal volume & issue
Vol. 9, no. 24
pp. 26736 – 26736

Abstract

Read online

No abstracts available.